Endometrial Adenocarcinoma — Trials

Endometrial Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 18
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03836157	Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	withdrawn	Phase 2	0	University of OklahomaOTHER	1	Jun 27, 2019	clinicaltrials
NCT01943058	Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer	withdrawn	Phase 2	0	University of Southern CaliforniaOTHER	0	Sep 10, 2014	clinicaltrials